Bookmark

Add to MyYahoo RSS

Novavax News

News on Novavax (Ticker: NVAX) continually updated from thousands of sources around the net.

Monday Aug 25 | Seeking Alpha

Reasons To Accumulate Shares Of Novavax

NVAX has a technology platform for the development of multiple vaccines, a robust R&D budget, growing revenue, its own manufacturing capability, and trial results published in NEJM.

Comment?

Related Topix: Biotech, Healthcare Industry, Food and Drug Administration, Influenza, Health

Fri Aug 22, 2014

Forbes.com

Use Options For a Chance To Buy Novavax at a 31% Discount

Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Friday, the stock is now 10.3% higher than the offering price.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets

Sat Aug 16, 2014

PR-inside.com

"Novavax, Inc. (NVAX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Published

It discovers vaccines and vaccine adjuvants that address a wide range of infectious diseases.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Infectious Diseases, Science / Technology, Nanotechnology, Influenza, Health, Bird Flu

Fri Aug 15, 2014

Seeking Alpha

Buy An Unprofitable Company That Will Use Your Capital To Become Profitable

A company that is profitable enough to pay shareholders dividends and repurchase its own shares obviously doesn't need your capital, but may be a good place to deposit your cash.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Wed Aug 13, 2014

AmericanBankingNews.com

Citigroup Inc. Initiates Coverage on Novavax

The firm set a "buy" rating on the stock. Separately, analysts at FBR Capital Markets cut their price target on shares of Novavax from $11.00 to $10.00 in a research note on Thursday, August 7th.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Tue Aug 12, 2014

AmericanBankingNews.com

Short Interest in Novavax Expands By 6.2%

Shares of Novavax saw a significant increase in short interest during the month of July.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Aug 07, 2014

Hispanic Business

Novavax to Present at the Wedbush Securities Life Sciences Management Access Conference

A live webcast link for the presentation will be available via the company's website at www.novavax.com under Investor Info/Events.

Comment?

Related Topix: Biotech, Healthcare Industry, Nanotechnology, Science / Technology

Wed Aug 06, 2014

BioSpace

Novavax, Inc. Reports Second-Quarter 2014 Financial Results

Novavax, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today reported its financial results for the second quarter and six months ended June 30, 2014.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Science / Technology, Nanotechnology, Vaccinations, Health, Synagis, Palivizumab (generic), Influenza, Bird Flu

Wed Jul 30, 2014

BioSpace

Novavax, Inc. To Host Conference Call To Discuss Second Quarter 2014...

Novavax, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, announced today that it will report its financial results for the second quarter of 2014 on Wednesday, August 6, 2014, after market close.

Comment?

Related Topix: Biotech, Healthcare Industry, Nanotechnology, Science / Technology

•••
•••
•••
•••

Woodbridge Jobs

•••
•••
•••
•••